Stay updated with breaking news from Cell Processing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- GPB Scientific, Inc., a key enabling technology company for cell therapy manufacturing, announced the hiring of Gaurav Vij and Joan Haab, PhD,...
/PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and...
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Fetal Bovine Serum Global Market Report 2021: COVID-19 Growth And Change The Business Research Company’s Fetal Bovine Serum Global Market Report 2021: COVID-19 Growth And Change LONDON, GREATER LONDON, UK, June 3, 2021 /EINPresswire.com/ -- The increasing demand for biopharmaceuticals is expected to drive the growth of the fetal bovine serum market in the forecast period. A biopharmaceutical is a medicinal product that is derived from biological sources such as animals, humans, and microorganisms using biotechnology. Fetal bovine serum (FBS) is the most widely used substitute for animal cel...
Company's 52-week low was at $63.41 Price action over last quarter: Up 16.87% Company Profile Haemonetics Corp sells products used to process, handle, and analyze blood. The firm sells products in four categories: Plasma, Hemostasis Management, Blood Center and Cell Processing. The Plasma business includes plasma collection devices and disposables. Hemostasis Management includes devices and methodologies for measuring coagulation characteristics of blood, Blood Center includes blood collection and processing devices and disposables for red cells and Cell Processing include surgical blood salv...